Evidence map›Paper›PMID 40066028›Full record

ArticleHeliyon2025

On the addition of Au and Pt to a Fe-Mn-Si alloy for biodegradable implants.

J N Lemke, J Fiocchi, C A Biffi, A Coda, A Tuissi

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J N LemkeSAES Getters S.p. A., Viale Italia 77, Lainate (MI), 20045, Italy.
J FiocchiCNR ICMATE, National Research Council, Institute of Condensed Matter Chemistry and Technologies for Energy, Via Previati 1/E, Lecco, 23900, Italy.
C A BiffiCNR ICMATE, National Research Council, Institute of Condensed Matter Chemistry and Technologies for Energy, Via Previati 1/E, Lecco, 23900, Italy.
A CodaSAES Getters S.p. A., Viale Italia 77, Lainate (MI), 20045, Italy.
A TuissiCNR ICMATE, National Research Council, Institute of Condensed Matter Chemistry and Technologies for Energy, Via Previati 1/E, Lecco, 23900, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fe-Mn based alloys are particular promising for the development of temporary bioabsorbable implants. They exhibit good performance in biological tests, improved mechanical properties and more adequate degradation rates than pure iron for the targeted application. In addition, this system possesses an excellent processability, making it particular suitable for designing thin structures and tailoring the chemistry by alloying. Accordingly, earlier works indicated that by adding Si to Fe-Mn, mechanical properties and long-term degradation behaviour could be improved. This study builds up on the alloying approach adding a fourth noble element to further enhance degradation rate, strain-hardening performance and to pave the way for preparing functionally optimized implant materials as Pt and Au can increase radiopacity and their ions are potentially antibacterial. The alloys were prepared by arc-melting and processed into sheets. Dissolution behaviour was measured by electro-chemical corrosion and static degradation set-up, mechanical properties were studied in tensile mode. Particular emphasis is placed on the different evolution of microstructure in these alloys after rolling and its impact on passivation and degradation. This study demonstrates that quaternary Fe-Mn-Si-(Pt, Au) alloys can be prepared successfully, further accelerating degradation in comparison with ternary alloys.

Indexed as

Bioabsorbable metalsFe-Mn alloysIn-vitro degradationMechanical propertiesMicrostructureProcessing

Identifiers

PMID40066028
PMCPMC11891682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.